| Mercy Manor Transition Center | |
| 1000 Mineral Point Ave, Janesville, Wisconsin 53547 | |
| (608) 756-6050 | |
| Name | Mercy Manor Transition Center |
|---|---|
| Location | 1000 Mineral Point Ave, Janesville, Wisconsin |
| Certified By | Medicare |
| No. of Certified Beds | 28 |
| Occupancy Rate | 44.29% |
| Medicare ID (CCN) | 525666 |
| Legal Business Name | Mercy Health System Corporation |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1427105006 |
| Organization Name | MERCY HEALTH SYSTEM CORPORATION |
| Doing Business As | MERCY MANOR TRANSITION CENTER |
| Address | 1000 Mineral Point Ave, Janesville, WI 53548 |
| Phone Number | 608-756-3856 |
News Archive
A major clinical trial from the University of New South Wales (UNSW) reports that a medication called allopurinol, which is prescribed to about 20% of patients with chronic kidney disease (CKD), doesn't work as expected. The results are published in the New England Journal of Medicine on June 25, 2020.
More people than ever are able to resume working after a heart attack, but those working less or unable to work reported lower quality of life with increased depression and difficulty affording their medication, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.
Researchers at MIT have found that light therapy can enhance synaptic function and protect against cell death in Alzheimer's disease.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A major clinical trial from the University of New South Wales (UNSW) reports that a medication called allopurinol, which is prescribed to about 20% of patients with chronic kidney disease (CKD), doesn't work as expected. The results are published in the New England Journal of Medicine on June 25, 2020.
More people than ever are able to resume working after a heart attack, but those working less or unable to work reported lower quality of life with increased depression and difficulty affording their medication, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.
Researchers at MIT have found that light therapy can enhance synaptic function and protect against cell death in Alzheimer's disease.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|